Logo

Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bau… read more

Healthcare

Drug Manufacturers—Specialty & Generic

30 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$7.33

Price

+1.67%

$0.12

Market Cap

$2.711b

Mid

Price/Earnings

28.2x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

+28.9%

EBITDA Margin

-3.0%

Net Profit Margin

+6.0%

Free Cash Flow Margin
Revenue

$9.832b

+2.4%

1y CAGR

+2.2%

3y CAGR

+2.9%

5y CAGR
Earnings

$98m

+23.1%

1y CAGR

-26.2%

3y CAGR

-36.6%

5y CAGR
EPS

$0.26

+23.5%

1y CAGR

-26.0%

3y CAGR

-36.1%

5y CAGR
Book Value

$147m

$27.266b

Assets

$27.119b

Liabilities

$21.738b

Debt
Debt to Assets

79.7%

7.6x

Debt to EBITDA
Free Cash Flow

$1.122b

+10.4%

1y CAGR

-0.1%

3y CAGR

+10.5%

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases